Status:
TERMINATED
To Assess the Anti-adhesive Effect and Safety of Protescal
Lead Sponsor:
LG Life Sciences
Conditions:
Laparoscopic Myomectomy
Eligibility:
FEMALE
20+ years
Phase:
PHASE3
Brief Summary
This multicenter, randomized, single-blind study assessed the safety and efficacy of Protescal for the reduction of post-operative adhesion formation following myomectomy.
Detailed Description
The age of the patients participating in the study overed 20 years and included nonpregnant women requiring laparoscopic myomectomy and expected to undergo a second-look laparoscopy as part of their t...
Eligibility Criteria
Inclusion
- a woman who is over 20 years old
- a woman who needs a laparoscopic myomectomy
Exclusion
- a pregnant woman and a nursing mother
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01810900
Start Date
September 1 2012
End Date
December 1 2013
Last Update
March 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanyang University Hospital
Seoul, Seoul, South Korea, 133-791